Skip to main content

The Trial Lawyer's Journal

TLJ Small Logo
Close
Group 39053677
Share Your Story with Trial Lawyer’s Journal
Trial Lawyer’s Journal is built on the voices of trial lawyers like you. Share your journey, insights, and experiences through articles, interviews, and our podcast, Celebrating Justice.
Stay Updated
Sign up for our newsletter to get the latest from TLJ.



    Russell Budd

    President and Managing Shareholder | Baron & Budd, P.C.

    Russell Budd is a asbestos & mesothelioma, mass torts and class actions trial lawyer and president and managing shareholder of Baron & Budd, P.C. in Dallas, Texas. J.D., University of Texas School of Law (1979).

    Baron Budd logo

    Meet Russell

    Contact

    (214) 521-3605
    3102 Oak Lawn Avenue
    Suite 1100
    Dallas, Texas 75219

    Russell W. Budd is president and managing shareholder of Baron & Budd, P.C., the plaintiffs’ firm headquartered in Dallas, Texas. With more than 45 years in practice, he represents people and public entities harmed by corporate misconduct in asbestos and mesothelioma claims, pharmaceutical cases, consumer and banking class actions, environmental contamination and the national opioid litigation.

    Budd became a shareholder at the firm in 1985 and has led it as president since 2002. Beginning in the 1980s he represented asbestos victims nationwide, and in the early 2000s he was appointed by U.S. Trustees to creditors’ committees in numerous asbestos manufacturer bankruptcies. He was a chief negotiator in the Halliburton bankruptcy, which produced a $4 billion settlement, and helped negotiate settlements with United States Gypsum and W.R. Grace that funded asbestos trusts. He continues to sit on the trust advisory committees of more than a dozen asbestos trusts.

    In the opioid litigation, Judge Dan Aaron Polster of the Northern District of Ohio appointed Budd to the Plaintiffs’ Settlement Negotiation Team in MDL 2804, a group credited with negotiating more than $46 billion in settlements. He also represented New Mexico, negotiating $538 million in opioid settlements and supervising a seven-week trial that ended in a $500 million settlement with Walgreens. His other negotiated results include overdraft settlements with JPMorgan Chase and Bank of America and a multistate Avandia settlement with GlaxoSmithKline.

    Budd holds a law degree from the University of Texas and a bachelor’s degree, cum laude, from Trinity University. The American Association for Justice has honored him with its Harry M. Philo Trial Lawyer of the Year Award and its Steven J. Sharp Public Service Award. With his wife, Dorothy, he endowed The Budd Center for Involving Communities in Education at Southern Methodist University and The Budd Innocence Center at the University of Texas School of Law.

    Experience and Expertise

    Qualifications

    Timeline

    • J.D., University of Texas, 1979
    • B.A., cum laude, Trinity University, 1976
    • State Bar of Texas
    • State Bar of Michigan
    • United States Supreme Court
    • U.S. Court of Appeals for the Ninth Circuit
    • U.S. District Court for the Northern District of Texas
    • U.S. District Court for the District of New Mexico
    • U.S. District Court for the Southern District of Illinois
    • U.S. District Court for the Central District of Illinois

    Practice Areas

    Asbestos & Mesothelioma
    35%
    Mass Torts
    25%
    Class Actions
    20%
    Dangerous Drugs
    10%
    Environmental Litigation
    10%
    • American Bar Association
    • American Board of Trial Advocates
    • Association of Trial Lawyers of America
    • Dallas Bar Foundation (Life Fellow)
    • Dallas Trial Lawyers Association
    • Texas Trial Lawyers Association
    • Trial Lawyers for Public Justice
    • Trial Lawyers Care, Inc.
    • Lifetime Achievement, Texas Lawyer (2026)
    • Lawdragon Hall of Fame (2026)
    • Steven J. Sharp Public Service Award, American Association for Justice (2024)
    • Lifetime Achievement Award, Elite Trial Lawyers, National Law Journal (2024)
    • Top 10 National Asbestos/Mesothelioma Trial Lawyers, The National Trial Lawyers (2024-present)
    • Top 100 Civil Plaintiff Lawyers, The National Trial Lawyers (2017-present)
    • Lawyer of the Year, Mass Tort Litigation / Class Actions, Best Lawyers (2015, 2017)
    • Harry M. Philo Trial Lawyer of the Year Award, American Association for Justice (2010)
    • Wiedemann Wysocki National Finance Council Award, American Association for Justice (2007)
    • Texas Super Lawyers, Thomson Reuters (2003-present)
    • $4 Billion Settlement: Served as a chief negotiator in the Halliburton asbestos bankruptcy, which produced a $4 billion national settlement and the largest asbestos trust fund of its kind.
    • $3.9 Billion Settlement: Helped negotiate a $3.9 billion settlement with United States Gypsum for the benefit of asbestos claimants.
    • Nearly $3 Billion Settlement: Helped negotiate a cash and stock equity settlement of nearly $3 billion with W.R. Grace to fund an asbestos trust.
    • More Than $46 Billion in Opioid Settlements: Member of the court-appointed Plaintiffs' Settlement Negotiation Team in In re National Prescription Opiate Litigation, MDL 2804, which negotiated more than $46 billion in settlements with drug distributors, manufacturers and dispensers.
    • $538 Million in Settlements: Negotiated settlements with pharmacies, distributors and manufacturers valued at a combined $538 million on behalf of the state of New Mexico in its opioid litigation.
    • $500 Million Settlement: Supervised a seven-week trial for New Mexico in Santa Fe that ended in a $500 million settlement with Walgreens.
    • $410 Million Settlement: A leader in the checking account overdraft litigation that led to a $410 million settlement with Bank of America in 2011.
    • $110 Million Settlement: Chief negotiator for the 2012 JPMorgan Chase settlement in In re Checking Account Overdraft Litigation, which included $110 million in cash plus more than $100 million in business practice changes.
    • $177 Million Settlement: One of the negotiators of a $177 million settlement for seven states' attorneys general against GlaxoSmithKline over its marketing of the diabetes drug Avandia.

    Print is Alive

    Trial Lawyer's Journal sets a new standard for law journal publications. With limited ads and one-of-a-kind content, it was created to celebrate wins both in and outside the courtroom.